-
The Health Legacy of 9/11
People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program.
by Brad Jones
-
A New Guideline for Cervical Cancer Screening
Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Some Pancreatic Cancers Are Hereditary
A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
What Is ‘Chemo Brain’?
The National Cancer Institute's Todd Horowitz discusses cancer-related cognitive impairment.
by Anna Azvolinsky
-
Predicting Acute Myeloid Leukemia
Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
by Anna Azvolinsky
-
Healthy Habits
Unhealthy ProcessEating ultraprocessed foods may be linked to an increased risk of certain cancers.
by Kendall Morgan
-
From the Editor-in-Chief
Synthetic Lethality and Cancer: Aiming an Arrow at Achilles’ HeelInsights about synthetic lethality have been used to develop cancer treatments.
by William G. Nelson, MD, PhD
-
Recognizing AI’s Potential
Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.
by Stephen Ornes
-
Policy Matters
Putting an End to Cancer Health DisparitiesCancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.
by Michael A. Caligiuri, MD
-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore